Literature DB >> 10960520

Differentiation of autologous ABO, RHD, RHCE, KEL, JK, and FY blood group genotypes by analysis of peripheral blood samples of patients who have recently received multiple transfusions.

P Rozman1, T Dovc, C Gassner.   

Abstract

BACKGROUND: After multiple transfusions, the serologic typing of autologous blood group phenotypes is difficult, because of mixed RBC populations. The genotyping of ABO, Rh, Kell, Kidd, and Duffy systems could be used to determine autologous blood group antigen status. STUDY DESIGN AND METHODS: Blood samples from patients and donors were analyzed before and after 26 multiple-transfusion events. An average of 6.9 non-WBC-reduced RBC units with an average age of 5.9 days were administered per transfusion event. The average period of blood sampling after transfusions was 5.3 days. All samples were serologically phenotyped for ABO, Rh, Kell, Kidd, and Duffy. Pretransfusion, posttransfusion, and buccal samples from patients were genotyped for the corresponding alleles by a uniform PCR sequence-specific primer protocol that allowed their simultaneous determination within 3 hours.
RESULTS: All posttransfusion samples exhibited mixed-cell populations of various blood group systems on serologic testing. Genotyping from peripheral blood produced results identical to the autologous blood group phenotypes, regardless of the amount of blood transfused or of the length of the sampling period after transfusion.
CONCLUSION: A fast and reliable PCR-sequence-specific primer DNA genotyping assay for simultaneous determination of autologous ABO, Rh, Kell, Kidd, and Duffy blood groups can be performed on peripheral blood samples, even though the patients have recently received multiple transfusions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960520     DOI: 10.1046/j.1537-2995.2000.40080936.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  18 in total

1.  Blood group genotyping facilitates transfusion of beta-thalassemia patients.

Authors:  Lilian Castilho; Maria Rios; Jordão Pellegrino; Sara T O Saad; Fernando F Costa
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

2.  Benefits of blood group genotyping in multi-transfused patients from the south of Brazil.

Authors:  Gláucia Andréia Soares Guelsin; Ana Maria Sell; Lilian Castilho; Viviane Lika Masaki; Fabiano Cavalcante Melo; Margareth Naomi Hashimoto; Tatiana Takahashi Higa; Loide Souza Hirle; Jeane Eliete Laguila Visentainer
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Applications and Experience with PCR-Based Assays to Predict Blood Group Antigens.

Authors:  Marion E Reid
Journal:  Transfus Med Hemother       Date:  2009-06       Impact factor: 3.747

4.  Molecular immunohaematology round table discussions at the AABB Annual Meeting, Boston 2012.

Authors:  Willy A Flegel; Susan T Johnson; Margaret A Keller; Ellen B Klapper; Hanh M Khuu; Joann M Moulds; Axel W Seltsam; Gary Stack; Maryse St-Louis; Christopher A Tormey; Franz F Wagner; Christof Weinstock; Mark H Yazer; Gregory A Denomme
Journal:  Blood Transfus       Date:  2013-10-18       Impact factor: 3.443

5.  Rapid, single-subject genotyping to predict red blood cell antigen expression.

Authors:  S L Slezak; S Adams; H Lee-Stroka; J E Martin; L Caruccio; D F Stroncek
Journal:  Immunohematology       Date:  2008

6.  Applying molecular immunohaematology to regularly transfused thalassaemic patients in Thailand.

Authors:  Pairaya Rujirojindakul; Willy A Flegel
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

7.  ABO genotyping: the quest for clinical applications.

Authors:  Willy A Flegel
Journal:  Blood Transfus       Date:  2012-11-27       Impact factor: 3.443

8.  Why do we use serological blood group phenotype determination in chronically transfused patients?

Authors:  Franz F Wagner
Journal:  Blood Transfus       Date:  2013-12-11       Impact factor: 3.443

9.  Kidd Blood Group Genotyping for Thalassemia Patient in Iran.

Authors:  Seyedeh Farzaneh Jalali; Arezoo Oodi; Azita Azarkeivan; Samira Gudarzi; Naser Amirizadeh
Journal:  Indian J Hematol Blood Transfus       Date:  2020-04-29       Impact factor: 0.900

Review 10.  Transfusion in the age of molecular diagnostics.

Authors:  Marion E Reid
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.